These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 30620247)

  • 1. Legally Lethal Kratom: A Herbal Supplement with Overdose Potential.
    Palasamudram Shekar S; Rojas EE; D'Angelo CC; Gillenwater SR; Martinez Galvis NP
    J Psychoactive Drugs; 2019; 51(1):28-30. PubMed ID: 30620247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kratom: Implications for Health Care Providers.
    Goldin D; Salani D; Mckay M
    J Psychosoc Nurs Ment Health Serv; 2019 Dec; 57(12):15-20. PubMed ID: 31774129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kratom-Induced Cholestatic Liver Injury and Its Conservative Management.
    Fernandes CT; Iqbal U; Tighe SP; Ahmed A
    J Investig Med High Impact Case Rep; 2019; 7():2324709619836138. PubMed ID: 30920318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Kratom Dependence With Buprenorphine-Naloxone Maintenance.
    Buresh M
    J Addict Med; 2018; 12(6):481-483. PubMed ID: 29944481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute liver injury following short-term use of the herbal supplement kratom.
    Umbehr G; Lukaszewicz M
    JAAPA; 2022 Feb; 35(2):39-41. PubMed ID: 35076438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Kratom Withdrawal and Addiction With Buprenorphine.
    Khazaeli A; Jerry JM; Vazirian M
    J Addict Med; 2018; 12(6):493-495. PubMed ID: 30383616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Addictive Potential and Challenges with Use of the "Herbal Supplement" Kratom: A Case Report and Literature Review.
    Anand A; Hosanagar A
    Pain Med; 2022 Jan; 23(1):4-9. PubMed ID: 33822210
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute Renal Insufficiency Associated With Consumption of Hydrocodone- and Morphine-Adulterated Kratom (Mitragyna Speciosa).
    LeSaint KT; Yin S; Sharma A; Avery BA; McCurdy CR; Waksman JC
    J Emerg Med; 2022 Jul; 63(1):e28-e30. PubMed ID: 35940982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatality of 33-Year-Old Man Involving Kratom Toxicity.
    Matson M; Schenk N
    J Forensic Sci; 2019 Nov; 64(6):1933-1935. PubMed ID: 31121058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring a Crisis: Questioning the Use of Naloxone Administrations as a Marker for Opioid Overdoses in a Large U.S. EMS System.
    Grover JM; Alabdrabalnabi T; Patel MD; Bachman MW; Platts-Mills TF; Cabanas JG; Williams JG
    Prehosp Emerg Care; 2018; 22(3):281-289. PubMed ID: 29297739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pressure Necrosis Requiring Fasciotomy After Kratom Overdose.
    Tobarran N; Wolf C; Cumpston KL; Wills BK
    J Addict Med; 2022 Mar-Apr 01; 16(2):252-253. PubMed ID: 34001773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kratom use disorder: a primer for primary care physicians.
    Groff D; Stuckey H; Philpott C; Van Dyke E; Silvis M; Leong SL; Bone C
    J Addict Dis; 2022; 40(1):131-141. PubMed ID: 34281482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural drugs, not so natural effects: Neonatal abstinence syndrome secondary to 'kratom'.
    Davidson L; Rawat M; Stojanovski S; Chandrasekharan P
    J Neonatal Perinatal Med; 2019; 12(1):109-112. PubMed ID: 30149482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kratom Use and Toxicities in the United States.
    Eggleston W; Stoppacher R; Suen K; Marraffa JM; Nelson LS
    Pharmacotherapy; 2019 Jul; 39(7):775-777. PubMed ID: 31099038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Case of Potential Pharmacokinetic Kratom-drug Interactions Resulting in Toxicity and Subsequent Treatment of Kratom Use Disorder With Buprenorphine/Naloxone.
    Brogdon HD; McPhee MM; Paine MF; Cox EJ; Burns AG
    J Addict Med; 2022 Sep-Oct 01; 16(5):606-609. PubMed ID: 35165231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of deaths associated with kratom use.
    Corkery JM; Streete P; Claridge H; Goodair C; Papanti D; Orsolini L; Schifano F; Sikka K; Körber S; Hendricks A
    J Psychopharmacol; 2019 Sep; 33(9):1102-1123. PubMed ID: 31429622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-Induced Liver Injury Caused by Kratom Use as an Alternative Pain Treatment Amid an Ongoing Opioid Epidemic.
    Osborne CS; Overstreet AN; Rockey DC; Schreiner AD
    J Investig Med High Impact Case Rep; 2019; 7():2324709619826167. PubMed ID: 30791718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The therapeutic potential of kratom.
    Grundmann O; Brown PN; Henningfield J; Swogger M; Walsh Z
    Addiction; 2018 Oct; 113(10):1951-1953. PubMed ID: 29949213
    [No Abstract]   [Full Text] [Related]  

  • 19. Self-treatment of opioid withdrawal with a dietary supplement, Kratom.
    Boyer EW; Babu KM; Macalino GE
    Am J Addict; 2007; 16(5):352-6. PubMed ID: 17882605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kratom: An Emerging Issue and Need for Regulations in the United States.
    Shah K; Tankersley W; Mekala H
    Prim Care Companion CNS Disord; 2021 Feb; 23(1):. PubMed ID: 34000147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.